CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $963,000 | +324.2% | 18,643 | +103.9% | 0.01% | +250.0% |
Q2 2022 | $227,000 | -9.6% | 9,141 | -8.6% | 0.00% | +100.0% |
Q1 2022 | $251,000 | -24.6% | 9,999 | +9.2% | 0.00% | 0.0% |
Q4 2021 | $333,000 | +20.7% | 9,158 | +70.3% | 0.00% | -50.0% |
Q1 2021 | $276,000 | +1.5% | 5,379 | +22.5% | 0.00% | 0.0% |
Q4 2020 | $272,000 | +6700.0% | 4,390 | +683.9% | 0.00% | – |
Q1 2014 | $4,000 | +33.3% | 560 | 0.0% | 0.00% | – |
Q4 2013 | $3,000 | -75.0% | 560 | -73.1% | 0.00% | – |
Q3 2013 | $12,000 | -25.0% | 2,084 | +82.8% | 0.00% | – |
Q2 2013 | $16,000 | – | 1,140 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
Birchview Capital, LP | 25,000 | $428,000 | 0.29% |